<DOC>
	<DOCNO>NCT01265550</DOCNO>
	<brief_summary>Background : Gastroesophageal reflux disease ( GERD ) , affect least 20 % adult Americans , may especially common severe Veteran patient . Proton pump inhibitor ( PPIs ) , block gastric acid production , effective medication GERD , VA spend $ 177 million year outpatient PPI prescription . PPIs prevent reflux non-acidic material completely eliminate esophageal acid exposure , however , bothersome GERD symptom persist approximately 40 % patient treat PPIs . Recent study use new technique esophageal pH/ impedance monitoring , detect reflux acidic non-acidic material , show PPI-resistant GERD symptom correlate episode reflux ( acidic and/or non-acidic ) approximately one-half patient . For patient , antireflux operation might relieve symptom obviate expense ineffective PPI therapy , efficacy modern , laparoscopic fundoplication regard clear . For patient PPI-resistant GERD symptom , furthermore , efficacy medication prevent gastroesophageal reflux ( e.g . baclofen ) diminish pain esophageal origin ( e.g . neurotropic agent like desipramine ) also clear . Study Hypothesis : Laparoscopic antireflux surgery ( Nissen fundoplication ) superior medical therapy ( PPIs plus baclofen desipramine ) GERD patient , PPIs , persistent episode heartburn associate reflux episode abnormal esophageal acid exposure esophageal pH/impedance monitoring . Study Goals : The primary goal compare efficacy laparoscopic Nissen fundoplication medical therapy ( PPIs plus baclofen desipramine ) GERD patient , PPIs , persistent episode heartburn associate reflux episode abnormal esophageal acid exposure esophageal pH/impedance monitoring , compare efficacy therapy placebo . Secondary goal : 1 ) To determine frequency non-GERD disorder underlie `` PPI failure , '' 2 ) To determine frequency functional gastrointestinal symptom , anxiety depression patient persistent heartburn PPIs , 3 ) To determine whether functional gastrointestinal symptom , anxiety depression associate outcomes medical surgical therapy , 4 ) To determine whether outcome Nissen fundoplication associate adherence technical aspect operation . Study Design : At 15 VA medical center , 30-month recruitment period enroll 393 patient heartburn refractory PPI therapy . Patients baseline GERD symptom score use GERD Health-Related Quality Life ( GERD-HRQL ) index , endoscopy , esophageal manometry esophageal pH/impedance monitoring PPI therapy . Patients episodes heartburn associate reflux episode abnormal esophageal acid exposure esophageal pH/impedance monitoring randomize one three treatment group : Surgical Treatment ( laparoscopic Nissen fundoplication ) , Active Medical Treatment ( omeprazole baclofen initially ; desipramine baclofen failure ) Placebo Medical Treatment ( omeprazole , placebo baclofen , placebo desipramine ) . All patient quarterly clinic visit symptom score laboratory test . At one year , patient final symptom score repeat endoscopy , esophageal manometry esophageal pH/impedance monitoring . Treatment success define 50 % improvement GERD-HRQL score 12 month . Patients also complete Hospital Anxiety Depression Scale ( HADS ) , Rome III Functional GI Disorders Questionnaire Short-Form Health Survey ( SF-36 ) baseline one year . The result correlate treatment outcome .</brief_summary>
	<brief_title>A Randomized Trial Medical Surgical Treatments Patients With GERD Symptoms That Are Refractory Proton Pump Inhibitors</brief_title>
	<detailed_description />
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Desipramine</mesh_term>
	<criteria>Age 1864 year History heartburn ( define burn sensation retrosternal area chest ) refractory antisecretory medication Initial GERDHRQL : Total score must 6 least one six heartburn question must score 2 GERDHRQL two week treatment omeprazole : Total score must &gt; 50 % initial GERDHRQL score least one six heartburn question must score 2 Either follow baseline esophageal pH/multichannel intraluminal impedance ( MII ) monitoring patient omeprazole 20 mg two time day ( BID ) : Positive symptom association probability ( SAP ) ( &gt; 95 % ) acid reflux , nonacid reflux reflux . Abnormal acid reflux ( esophageal pH &lt; 4 4.2 % 24hour monitoring period ) Patients heartburn , define burn sensation chest Patients unwilling unable provide inform consent Pregnancy woman unwilling use effective contraception Age &lt; 18 &gt; 64 year History surgery stomach esophagus History seizure disorder History heart block History glaucoma Allergy previous inability tolerate study medication ( omeprazole , baclofen , desipramine ) Esophageal varix Cirrhosis Comorbidity sufficient severity preclude elective surgery ( e.g . pulmonary , cardiac , renal , liver disease ) History disorder cause medicallyrefractory `` GERD symptom '' ( eosinophilic esophagitis , neoplasms upper gastrointestinal tract , gastroparesis , achalasia ) Myocardial infarction within past 6 month History bipolar disorder , schizophrenia suicidal thought suicide Current use thioridazine ( Mellaril ) , monoamine oxidase inhibitor , pimozide , tricyclic antidepressant ( TCAs ) , linezolid , metoclopramide Current use clopidogrel Patients contraindication study medication require therapy medication clinically important drug interaction study medication ( omeprazole , baclofen , desipramine ) Patients , judgment PI , suitable candidate therapy study medication ( omeprazole , baclofen , desipramine ) Initial GERDHRQL score : Total score &lt; 6 and/or heartburn score &lt; 2 Inability tolerate omeprazole 2week treatment phase ( randomization ) GERDHRQL two week treatment omeprazole : Total score 50 % initial GERDHRQL score and/or heartburn score &lt; 2 Laboratory abnormality include : Platelet count &lt; 100,000 international normalize ratio ( INR ) &gt; 1.5 ( anticoagulant ) Serum creatinine &gt; 2.0 mg per deciliter Endoscopic abnormalities include : Los Angeles Classification Oesophagitis ( LA grade ) C D reflux esophagitis Active ulceration esophagus due reflux esophagitis Candida esophagitis Esophageal varix Active ulceration stomach and/or duodenum Neoplasm esophagus , stomach duodenum Gastric outlet obstruction Eosinophilic esophagitis ( 15 eosinophil per high power field esophageal biopsy specimen ) Manometric abnormality include : Achalasia Complete aperistalsis Negative SAP ( 95 % ) acid reflux , nonacid reflux reflux baseline combine esophageal pH/MII monitoring normal acid reflux ( esophageal pH &lt; 4 &lt; 4.2 % 24hour monitoring period ) Study surgeon identifies contraindication laparoscopic Nissen fundoplication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>